Learn more about entyvio® (vedolizumab), a biologic treatment for moderate to severe ulcerative colitis or crohn's disease in adults. Entyvio is indicated in adults for the treatment of Moderately to severely active ulcerative colitis (uc) Moderately to severely active crohn's disease (cd) Insert the syringe needle into the vial through the center of the stopper and direct the stream of sterile water for injection to the glass wall of the vial to avoid excessive foaming Gently swirl the vial for at least 15 seconds to dissolve the lyophilized powder
Do not vigorously shake or invert. Takeda pharmaceuticals amer ca, inc August 2021 s disease in adults Ulcerative colitis practice guidelines in adults American college of gastroenterology, practice parameters committee These highlights do not include all the information needed to use entyvio safely and effectively
American college of gastroenterology clinical guideline Management of crohn’s disease in adults. Entyvio® dosing and administration for iv infusion and subcutaneous injection Find infusion schedule, storage, and injection site information.
OPEN
